Red blood cell (RBC) membrane proteomics--Part II: Comparative proteomics and RBC patho-physiology.
Membrane proteomics offers unprecedented possibilities to compare protein expression in health and disease leading potentially to the identification of markers, of targets for therapeutics and to a better understanding of disease mechanisms. From transfusion medicine to infectious diseases, from cardiovascular affections to diabetes, comparative proteomics has made a contribution to the identification of proteins unique to RBCs of patients with specific illnesses shedding light on possible RBC markers for systemic diseases. In this review we will provide a short overview of some of the main achievements obtained by comparative proteomics in the field of RBC-related local and systemic diseases and suggest some additional areas of RBCs research to which comparative proteomics approaches could be fruitfully applied or extended in combination with biochemical techniques.
Pasini
Erica M
EM
Biomedical Primate Research Centre, Lange Kleiweg 139, 2288 GJ Rijswijk, The Netherlands.
Lutz
Hans U
HU
Mann
Matthias
M
Thomas
Alan W
AW
D000740:Anemia / Q000473:pathology / Q000503:physiopathology; D000818:Animals; D001803:Blood Transfusion / Q000379:methods / Q000706:statistics & numerical data; D004194:Disease; D004910:Erythrocyte Membrane / Q000378:metabolism*; D004912:Erythrocytes / Q000378:metabolism* / Q000473:pathology* / Q000502:physiology; D006706:Homeostasis / Q000502:physiology; D006801:Humans; D008954:Models, Biological; D040901:Proteomics / Q000379:methods*; D014183:Transplantation, Heterologous / Q000379:methods